Results 121 to 130 of about 198,110 (334)

Evaluation of the Therapeutic Potential of Bioactive Materials Based on a Complex of Oxidovanadium(IV) and Exopolysaccharide Levan in a Model of Insulin Resistance in Mice

open access: yesChemMedChem, EarlyView.
A low‐toxicity bioactive composition of oxidovanadium(IV) and exopolysaccharide levan is synthesized, characterized, and shown to reduce hyperglycemia, hypertriglyceridemia, and TyG index in a mice model of dexamethasone‐induced insulin resistance. Bioactive compositions containing vanadium complexes have been a viable strategy for constructing more ...
Amanda K. J. P. F. da Silva   +8 more
wiley   +1 more source

Specific food intolerance. [PDF]

open access: bronze, 1985
AileenP. Burford-Mason, J M T Willoughby
openalex   +1 more source

Body Image Surveys to Address Social Appearance Anxiety in Women at Risk of Eating Psychopathology: An Acceptability, Feasibility and Preliminary Efficacy Study, Using a Wait‐List Randomized Controlled Design

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective The study investigated the feasibility, acceptability and preliminary efficacy of a body image survey intervention for women at risk of eating psychopathology. Method A randomized wait‐list control design was used. The preregistered study (https://doi.org/10.17605/OSF.IO/ZQPEU) had ethical clearance and met recruitment targets ...
Emma Giles, Glenn Waller
wiley   +1 more source

The possibility of using barium sulfate stimulated luminol-dependent chemiluminescence method for diagnostics of food dye tartrazine intolerance

open access: yesКубанский научный медицинский вестник, 2014
We investigated the intensity of barium sulfate stimulated luminol-dependent chemiluminescence (SLCL) blood after pre-incubation of blood samples with food dye tartrazine used at different concentrations in healthy donors and patients with asthmatic ...
S. V. Chausova   +5 more
doaj  

Implementation of guideline‐recommended medical therapy for patients with heart failure in Europe

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 790-798, April 2025.
Abstract Physicians' adherence to guideline‐recommended heart failure (HF) treatment remains suboptimal, especially regarding the target doses. In particular, there is evidence that non‐cardiologists are less compliant with HF guideline recommendations. This is likely to have a detrimental impact on patients' survival, readmissions and quality of life.
Maurizio Volterrani   +11 more
wiley   +1 more source

The Irritable Bowel Syndrome [PDF]

open access: yes, 2009
A 45 year old businessman presents at your clinic with a 2 year history of recurrent abdominal pain, associated with frequent bouts of diarrhoea. The pain is relieved by defaecation, but there is often a feeling of incomplete evacuation.
Zammit, Edward
core  

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

open access: yesEpilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

open access: yesEpilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy